Information for the public

What has NICE said?

What has NICE said?

Dexamethasone intravitreal implant (Ozurdex) is recommended as a possible treatment for people with sight problems caused by diabetic macular oedema if:

  • there is an artificial lens in the eye to be treated, and

  • their diabetic macular oedema has not improved with non‑corticosteroid treatment, or such treatment is not suitable for them.

What does this mean for me?

If you have diabetic macular oedema and your doctor thinks that dexamethasone intravitreal implant is the right treatment, you should be able to have the treatment on the NHS.

Dexamethasone intravitreal implant should be available on the NHS within 3 months of the guidance being issued.

If you are not eligible for treatment as described above, you should be able to continue having treatment with dexamethasone intravitreal implant until you and your doctor decide it is the right time to stop.

  • Information Standard